Measurement of caspase 3/7 activity further confirmed that G6PD knockdown increased oxaliplatin sensitivity in CRC cells after a 48 h incubation and that supplementation with NAC prevented cell death (Figure 4c). The gene discussed is G6PD; the disease is colorectal carcinoma.